Adherence to oral anticoagulant therapy in secondary stroke prevention – impact of the novel oral anticoagulants

BACKGROUND: Oral anticoagulant therapy (OAT) potently prevents strokes in patients with atrial fibrillation. Vitamin K antagonists (VKA) have been the standard of care for long-term OAT for decades, but non-VKA oral anticoagulants (NOAC) have recently been approved for this indication, and raised ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Luger, Sebastian, Hohmann, Carina, Niemann, Daniela, Kraft, Peter, Gunreben, Ignaz, Neumann-Haefelin, Tobias, Kleinschnitz, Christoph, Steinmetz, Helmuth, Foerch, Christian, Pfeilschifter, Waltraud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4664488/
https://www.ncbi.nlm.nih.gov/pubmed/26648702
http://dx.doi.org/10.2147/PPA.S88994

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4664488/
https://www.ncbi.nlm.nih.gov/pubmed/26648702
http://dx.doi.org/10.2147/PPA.S88994

Ejemplares similares